An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Rijcken CA, Tobi H, Vergouwen AC, de Jong-van den Berg LT.Rijcken CA, et al.Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):365-70. doi: 10.1002/pds.951.Pharmacoepidemiol Drug Saf. 2004.PMID: 15170765
Rijcken CA, Boelema GJ, Slooff CJ, Beuger PJ, Tanja TA, de Jong-van den Berg LT.Rijcken CA, et al.Pharmacopsychiatry. 2003 Sep;36(5):187-91. doi: 10.1055/s-2003-43048.Pharmacopsychiatry. 2003.PMID: 14571353
Schirm E, Pedersen L, Tobi H, Nielsen GL, Sørensen HT, de Jong-van den Berg LT.Schirm E, et al.Pharmacoepidemiol Drug Saf. 2004 Sep;13(9):609-13. doi: 10.1002/pds.959.Pharmacoepidemiol Drug Saf. 2004.PMID: 15362083
Rijcken CA, Knegtering H, Bruggeman R, Tobi H, de Jong-van den Berg LT.Rijcken CA, et al.Psychiatry Res. 2005 Apr 15;134(2):143-50. doi: 10.1016/j.psychres.2003.06.005.Psychiatry Res. 2005.PMID: 15840415
Tobi H, Faber A, van den Berg PB, Drane JW, de Jong-van den Berg LT.Tobi H, et al.Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):405-11. doi: 10.1002/pds.1304.Pharmacoepidemiol Drug Saf. 2007.PMID: 16981229Free article.
Schirm E, Tobi H, van Puijenbroek EP, Monster-Simons MH, de Jong-van den Berg LT.Schirm E, et al.Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):159-65. doi: 10.1002/pds.843.Pharmacoepidemiol Drug Saf. 2004.PMID: 15072115
Schirm E, Monster TB, de Vries R, van den Berg PB, de Jong-van den Berg LT, Tobi H.Schirm E, et al.Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):173-9. doi: 10.1002/pds.882.Pharmacoepidemiol Drug Saf. 2004.PMID: 15072117
Tobi H, van den Heuvel NJ, de Jong-van den Berg LT.Tobi H, et al.Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):497-500. doi: 10.1002/pds.928.Pharmacoepidemiol Drug Saf. 2004.PMID: 15269934
Rijcken CA, Dekens-Konter JA, Knegtering H, de Jong-van den Berg LT.Rijcken CA, et al.Pharm World Sci. 2001 Oct;23(5):169-72. doi: 10.1023/a:1012463320661.Pharm World Sci. 2001.PMID: 11721669Review.
Tobi H, Meijer WM, Tuinstra J, de Jong-van den Berg LT.Tobi H, et al.Pharm World Sci. 2003 Oct;25(5):203-6. doi: 10.1023/a:1025836704150.Pharm World Sci. 2003.PMID: 14584226